Science
Waisman Biomanufacturing partners with GigaGen to manufacture new COVID-19 drug – Mirage News
Waisman Biomanufacturing at the University of Wisconsin-Madison will begin manufacturing a new drug to treat and prevent COVID-19, developed by…
Waisman Biomanufacturing at the University of Wisconsin-Madison will begin manufacturing a new drug to treat and prevent COVID-19, developed by California-based biotech company GigaGen.
The drug, called GIGA-2050, uses a new approach similar to treating COVID-19 patients with convalescent plasma, or blood products from people recovering (convalescing) from an infection. Waisman Biomanufacturing was created to facilitate just this sort of development and testing of new types of drugs.
“Our miss…
-
Noosa News21 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News20 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
Business7 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General16 hours ago‘Potential’ hacker contacts Qantas over data breach